We are live on ! Find out more
EP

Elkhorn Partners Portfolio holdings

AUM $157M
1-Year Est. Return 11.91%
This Fund
S&P 500
This Quarter Est. Return
-8.95%
1 Year Est. Return
+11.91%
3 Year Est. Return
+31.51%
5 Year Est. Return
+35.62%
10 Year Est. Return
+87.18%
AUM
$138M
AUM Growth
-$17.9M
Cap. Flow
-$2.68M
Cap. Flow %
-1.94%
Top 10 Hldgs %
96.28%
Holding
51
New
3
Increased
25
Reduced
9
Closed
6

Sector Composition

Rank Sector Weight
1 Real Estate 47.18%
2 Financials 44.1%
3 Communication Services 3.49%
4 Technology 1.62%
5 Materials 0.92%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BHVN
51
DELISTED
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
-600
Closed -$87K

Similar funds

Elkhorn Partners's Q3 2022 Portfolio in Review

As of Q3 2022, Elkhorn Partners held 51 positions worth $138M, down 11% from $156M the previous quarter. Its ten largest holdings account for 96% of the portfolio.

Elkhorn Partners's Q3 2022 filing shows 3 new, 25 increased, 9 reduced and 6 closed positions. Its largest new stake was Oshkosh: 2,900 shares worth $204K. The largest sale was White Mountains Insurance, an estimated $4.39M.

By sector, the portfolio is most concentrated in Real Estate at 47% of assets, down from 50% a quarter earlier, followed by Financials and Communication Services.

  • Elkhorn Partners's largest Q3 2022 buy was Oshkosh: 2,900 shares worth $204K.
  • Elkhorn Partners added most to Kennedy-Wilson Holdings in Q3 2022, an estimated $1.58M increase.
  • Elkhorn Partners's biggest Q3 2022 reduction was White Mountains Insurance, cutting an estimated $4.39M.
  • Elkhorn Partners fully exited Global Blood Therapeutics, Inc. in Q3 2022, selling an estimated $594K.
  • Elkhorn Partners's ten largest holdings make up 96% of its $138M portfolio in Q3 2022.
  • Elkhorn Partners opened 3 new positions and closed 6 in Q3 2022.
  • Elkhorn Partners's portfolio value fell 11% quarter-over-quarter to $138M.

Based on Elkhorn Partners's 13F filing for Q3 2022, filed 14 Nov 2022.